lmsg.nhs.uk Report : Visit Site


  • Ranking Alexa Global: # 3,733,104

    Server:nginx...

    The main IP address: 35.189.96.120,Your server United States,Ann Arbor ISP:Merit Network Inc.  TLD:uk CountryCode:US

    The description :about the leicestershire medicines strategy group in common with other local health communities, the leicestershire medicines strategy group (lmsg) acknowledges the benefits of having a leicestershire...

    This report updates in 28-Jun-2018

Created Date:1996-08-00

Technical data of the lmsg.nhs.uk


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host lmsg.nhs.uk. Currently, hosted in United States and its service provider is Merit Network Inc. .

Latitude: 42.259864807129
Longitude: -83.71989440918
Country: United States (US)
City: Ann Arbor
Region: Michigan
ISP: Merit Network Inc.

the related websites

    amazon.com kernowmodelrailcentre.com cisco.com 

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

X-Cache:HIT: 1
Content-Encoding:gzip
Transfer-Encoding:chunked
X-Cache-Group:normal
Vary:Accept-Encoding,Cookie
Keep-Alive:timeout=20
X-Cacheable:SHORT
Server:nginx
X-Pass-Why:
Connection:keep-alive
Link:; rel="https://api.w.org/", ; rel=shortlink
Cache-Control:max-age=600, must-revalidate
Date:Wed, 27 Jun 2018 19:03:14 GMT
WPE-Backend:apache
X-Type:default
Content-Type:text/html; charset=UTF-8

DNS

soa:external.nhs.uk. hostmaster.nhs.uk. 2017091301 86400 3600 15000000 600
ns:nsb.nhs.uk.
nsa.nhs.uk.
ipv4:IP:35.189.96.120
ASN:15169
OWNER:GOOGLE - Google LLC, US
Country:US
mx:MX preference = 50, mail exchanger = mail.nhs.uk.

HtmlToText

you are using an outdated browser. please upgrade your browser to improve your experience. menu home traffic lights tas drug requests tas summaries and latest updates tas meeting minutes tas process leicestershire drug evaluations lmsg/tas meetings annual reports miscellaneous formulary guidelines shared care: listed alphabetically health community primary care secondary care formulary about lmsg about us newsletters lmsg meeting minutes quality innovation productivity prevention (qipp) members lmsg/tas meetings annual reports useful links leicestershire medicines strategy group home traffic lights tas drug requests tas summaries and latest updates tas meeting minutes tas process leicestershire drug evaluations lmsg/tas meetings annual reports miscellaneous formulary guidelines shared care: listed alphabetically health community primary care secondary care formulary about lmsg about us newsletters lmsg meeting minutes quality innovation productivity prevention (qipp) members lmsg/tas meetings annual reports useful links search the site: you are here: home traffic lights - latest updates last updated: 15/06/2018 other updates on this site drug name classification clinical indication comments aflibercept (eylea®) (updated) red wet age related macular degeneration. diabetic macular oedema. macular oedema due to central retinal vein occlusion and branch retinal vein occlusion. choroidal neovascularisation. in line with nice ta294 , nice ta346 , nice ta305 , nice ta409 , nice ta486 alimemazine (updated) green conditional various historic patients who have tried or not been suitable for other sedating antihistamines or melatonin. gp to continue prescribing. important: patients currently taking alimemazine should be discussed with the specialist and not have treatment stopped abruptly without a review. alimemazine (updated) red various historic patients who have not tried or been considered for alternatives. patients to be reviewed by secondary care. secondary care to prescribe if continuing treatment required. important: patients currently taking alimemazine should be discussed with the specialist and not have treatment stopped abruptly without a review. alimemazine (updated) black various new patients. current patients should be discussed with the prescribing specialist and not have treatment stopped abruptly without appropriate review. alprostadil uretheral sticks and injections (new) green erectile dysfunction not prescribable under the nhs for treatment of erectile dysfunction except in men who meet the criteria listed in part xviiib of the drug tariff. the prescription must be endorsed ‘sls’. maximum 4 doses per month to be prescribed. anastrozole (new) amber simple off label chemoprevention to reduce incidence of breast cancer. use in line with nice cg 164 argatroban (exembol®) (new) black for anticoagulation in adult patients with heparin-induced thrombocytopenia type ii. basiliximab (simulect®) (new) red immunosuppressive therapy for kidney transplant in adults and children/young people in line with nice ta 481 , nice ta 482 belatacept (nulojix®) (new) red immunosuppressive therapy for kidney transplant in adults and children/young people in line with nice ta 481 , nice ta 482 biosimilar trastuzumab (herzuma®) (new) black metastatic breast cancer, early breast cancer and metastatic gastric cancer. biosimilar trastuzumab (ontruzant®) (new) black for her2 positive metastatic and early stage breast cancer, her2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction brodalumab (kyntheum®) (new) red moderate to severe plaque psoriasis in line with nice ta 511 implementation date 21 st june 2018 budesonide 64mcg nasal spray (benacort®) (new) black budesonide and formeterol (fobumix®) easyhaler (new) green asthma cabozantinib (cabometyx®) (new) black treatment of advanced renal cell carcinoma. cariprazine (new) black schizophrenia ceftobiprole (zevtera®) (new) black for hospital and community-acquired pneumonia in adults. chondrosphere (spherox®) (new) red autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee in adults in line with nice ta 508 implementation date 7 th june 2018 ciprofloxacin 2mg/ml ear drops (cetraxal ®) (new) black acute otitis media not yet reviewed cladribine (new) red relapsing-remitting multiple sclerosis in line with nice ta 493 dermatophagoides pteronyssinus allergen extract (acarizax®) (new) red immunotherapy treatment for house dust mite and allergic rhinitis. dupilumab (dupixent®) (new) black emicizumab (hemlibra®) (new) black for prophylaxis of bleeding episodes enoxaparin becat prefilled syringes (new) black parenteral anticoagulant everolimus (certican®) (new) red immunosuppressive therapy for kidney transplant in adults and children/young people in line with nice ta 481 , nice ta 482 fibrinogen (riastap®) (new) red treatment of severe bleeding in acquired hypofibrinogenemia resulting from operative interventions, in particular after cardiac surgery fluticasone / azelastine nasal spray (dymista®) (updated) green rhinitis to be used in line with the allergic rhinitis pathway glecaprevir-pibrentasvir (maviret®) (new) red hepatitis c in line with nice ta 499 golimumab (new) red non-radiographic axial spondyloarthritis in line with nice ta 497 guselkumab (tremfya®) (new) black moderate to severe plaque psoriasis in adults histidine trytophan ketoglutarate manitol (custodiol®) (new) red for myocardial protection in complex cardiac surgery. for organ preservation in transplant surgery hydrocortisone (alkindi®)(granules in capsules for opening) (new) black adrenal insufficiency in infants interferon gamma (immukin®) (new) red for mycobacterial infections and pulmonary and miliary levetiracetam (new) green conditional palliative care in line with guidance conditional on recommendation from palliative care team. palliative care prescribing methadone (oral) (new) amber simple chronic pain with ongoing advice from specialist services on dose reduction midostaurin (rydapt®) (new) black newly diagnosed flt3 mutation-positive acute myeloid leukaemia, aggressive systemic mastocytosis, systemic mastocytosis with associated haematological neoplasm, or mast cell leukaemia. mycophenolate (updated) amber full sca immunosuppression following renal transplantation exception agreed to red status: full shared care to allow gps to continue supplying to historical patients still on shared care where appropriate for patient and the gp agrees. full sca mycophenolate (new) red immunosuppression following renal transplantation naloxone (new) green conditional palliative care in line with guidance. conditional on recommendation from palliative care team. palliative care prescribing naltrexone / bupropion m/r (mysimba®) (new) black managing obesity nice ta 494 not supported for managing obesity in adults ocrelizumab (ocrevus®) (new) black patiromer (veltassa®) (new) black pirfenidone (esbriet®) (updated) red for idiopathic pulmonary fibrosis in line with nice ta 504 (replaces nice ta 282 ) plasma-lyte 148 & 5% glucose solution for infusion (new) red source of water, electrolyte and calories or as a alkalinising agent quetiapine (new) green conditional palliative care in line with guidance. conditional on recommendation from palliative care team. palliative care prescribing rabbit anti-human thymocyte immunoglobulin (thymoglobuline®) (new) red immunosuppressive therapy for kidney transplant in adults and children/young people in line with nice ta 481 , nice ta 482 raloxifene (new) amber simple off label chemoprevention to reduce incidence of breast cancer. use in line with nice cg 164 ropivacaine 2 mg/ml solution for infusion dispensed via readyfusor® infusion pump (new) black for acute post operative pain in adults sofosbuvir–velpatasvir-voxilaprevir (vosevi®) (new) red for chronic hepatitis c implementation from 21st may 2018 in line with nice ta 504 tivozanib (fotivda®) (new) b

URL analysis for lmsg.nhs.uk


https://www.lmsg.nhs.uk/traffic-lights/view/1031
https://www.lmsg.nhs.uk/traffic-lights/view/1040
https://www.lmsg.nhs.uk/traffic-lights/view/1041
https://www.lmsg.nhs.uk/traffic-lights/view/1047
https://www.lmsg.nhs.uk/traffic-lights/view/236
https://www.lmsg.nhs.uk/guidelines/health-community/shared-care/
https://www.lmsg.nhs.uk/traffic-lights/view/1049
https://www.lmsg.nhs.uk/privacy-policy/
https://www.lmsg.nhs.uk/about-lmsg/meeting-notes/
https://www.lmsg.nhs.uk/therapeutic-advisory-service/
https://www.lmsg.nhs.uk/guidelines/health-community/
https://www.lmsg.nhs.uk/traffic-lights/view/1048
https://www.lmsg.nhs.uk/disclaimer/
https://www.lmsg.nhs.uk/traffic-lights/view/1051
https://www.lmsg.nhs.uk/traffic-lights/view/995
leicestercityccg.nhs.uk
leicestershire.formulary.co.uk
cite.co.uk
leicestershospitals.nhs.uk
cas.dh.gov.uk
westleicestershireccg.nhs.uk
loros.co.uk
nice.org.uk
eastleicestershireandrutlandccg.nhs.uk
leicspart.nhs.uk

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name:
nhs.uk

Registrant:
Department of Health

Registrant type:
UK Government Body

Registrant's address:
Health and Social Care Information Centre
Informatics Directorate
Department of Health
Princes Exchange
Princes Square
Leeds
West Yorkshire
LS1 4HY
GB


Registrar:
No registrar listed. This domain is directly registered with Nominet.

Relevant dates:
Registered on: before Aug-1996

Name servers:
nsa.nhs.uk. 194.176.105.223
nsb.nhs.uk. 80.2.101.230


WHOIS lookup made at 20:03:20 27-Jun-2018

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2018.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at https://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER uk.whois-servers.net

  ARGS nhs.uk

  PORT 43

  TYPE domain

OWNER

  ORGANIZATION Department of Health

TYPE
UK Government Body

ADDRESS
Health and Social Care Information Centre
Informatics Directorate
Department of Health
Princes Exchange
Princes Square
Leeds
West Yorkshire
LS1 4HY
GB

DOMAIN

  SPONSOR No registrar listed. This domain is directly registered with Nominet.

  CREATED 1996-08-00

NSERVER

  NSA.NHS.UK 194.176.105.223

  NSB.NHS.UK 80.2.101.230

  NAME nhs.uk

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at https://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.ulmsg.com
  • www.7lmsg.com
  • www.hlmsg.com
  • www.klmsg.com
  • www.jlmsg.com
  • www.ilmsg.com
  • www.8lmsg.com
  • www.ylmsg.com
  • www.lmsgebc.com
  • www.lmsgebc.com
  • www.lmsg3bc.com
  • www.lmsgwbc.com
  • www.lmsgsbc.com
  • www.lmsg#bc.com
  • www.lmsgdbc.com
  • www.lmsgfbc.com
  • www.lmsg&bc.com
  • www.lmsgrbc.com
  • www.urlw4ebc.com
  • www.lmsg4bc.com
  • www.lmsgc.com
  • www.lmsgbc.com
  • www.lmsgvc.com
  • www.lmsgvbc.com
  • www.lmsgvc.com
  • www.lmsg c.com
  • www.lmsg bc.com
  • www.lmsg c.com
  • www.lmsggc.com
  • www.lmsggbc.com
  • www.lmsggc.com
  • www.lmsgjc.com
  • www.lmsgjbc.com
  • www.lmsgjc.com
  • www.lmsgnc.com
  • www.lmsgnbc.com
  • www.lmsgnc.com
  • www.lmsghc.com
  • www.lmsghbc.com
  • www.lmsghc.com
  • www.lmsg.com
  • www.lmsgc.com
  • www.lmsgx.com
  • www.lmsgxc.com
  • www.lmsgx.com
  • www.lmsgf.com
  • www.lmsgfc.com
  • www.lmsgf.com
  • www.lmsgv.com
  • www.lmsgvc.com
  • www.lmsgv.com
  • www.lmsgd.com
  • www.lmsgdc.com
  • www.lmsgd.com
  • www.lmsgcb.com
  • www.lmsgcom
  • www.lmsg..com
  • www.lmsg/com
  • www.lmsg/.com
  • www.lmsg./com
  • www.lmsgncom
  • www.lmsgn.com
  • www.lmsg.ncom
  • www.lmsg;com
  • www.lmsg;.com
  • www.lmsg.;com
  • www.lmsglcom
  • www.lmsgl.com
  • www.lmsg.lcom
  • www.lmsg com
  • www.lmsg .com
  • www.lmsg. com
  • www.lmsg,com
  • www.lmsg,.com
  • www.lmsg.,com
  • www.lmsgmcom
  • www.lmsgm.com
  • www.lmsg.mcom
  • www.lmsg.ccom
  • www.lmsg.om
  • www.lmsg.ccom
  • www.lmsg.xom
  • www.lmsg.xcom
  • www.lmsg.cxom
  • www.lmsg.fom
  • www.lmsg.fcom
  • www.lmsg.cfom
  • www.lmsg.vom
  • www.lmsg.vcom
  • www.lmsg.cvom
  • www.lmsg.dom
  • www.lmsg.dcom
  • www.lmsg.cdom
  • www.lmsgc.om
  • www.lmsg.cm
  • www.lmsg.coom
  • www.lmsg.cpm
  • www.lmsg.cpom
  • www.lmsg.copm
  • www.lmsg.cim
  • www.lmsg.ciom
  • www.lmsg.coim
  • www.lmsg.ckm
  • www.lmsg.ckom
  • www.lmsg.cokm
  • www.lmsg.clm
  • www.lmsg.clom
  • www.lmsg.colm
  • www.lmsg.c0m
  • www.lmsg.c0om
  • www.lmsg.co0m
  • www.lmsg.c:m
  • www.lmsg.c:om
  • www.lmsg.co:m
  • www.lmsg.c9m
  • www.lmsg.c9om
  • www.lmsg.co9m
  • www.lmsg.ocm
  • www.lmsg.co
  • lmsg.nhs.ukm
  • www.lmsg.con
  • www.lmsg.conm
  • lmsg.nhs.ukn
  • www.lmsg.col
  • www.lmsg.colm
  • lmsg.nhs.ukl
  • www.lmsg.co
  • www.lmsg.co m
  • lmsg.nhs.uk
  • www.lmsg.cok
  • www.lmsg.cokm
  • lmsg.nhs.ukk
  • www.lmsg.co,
  • www.lmsg.co,m
  • lmsg.nhs.uk,
  • www.lmsg.coj
  • www.lmsg.cojm
  • lmsg.nhs.ukj
  • www.lmsg.cmo
Show All Mistakes Hide All Mistakes